scispace - formally typeset
J

Jeffrey I. Zink

Researcher at University of California, Los Angeles

Publications -  511
Citations -  46214

Jeffrey I. Zink is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Mesoporous silica & Excited state. The author has an hindex of 99, co-authored 509 publications receiving 42667 citations. Previous affiliations of Jeffrey I. Zink include University of Southern California & University of South Dakota.

Papers
More filters
Journal ArticleDOI

Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties.

TL;DR: The results demonstrate that metal oxide nanoparticles induce a range of biological responses that vary from cytotoxic to cytoprotective and can only be properly understood by using a tiered test strategy such as that developed for oxidative stress and adapted to study other aspects of nanoparticle toxicity.
Journal ArticleDOI

Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery

TL;DR: In this article, superparamagnetic iron oxide nanocrystals were encapsulated inside mesostructured silica spheres that were labeled with fluorescent dye molecules and coated with hydrophilic groups to prevent aggregation.
Journal ArticleDOI

Mesoporous silica nanoparticles in biomedical applications

TL;DR: This tutorial review provides an outlook on nanomaterials that are currently being used for theranostic purposes, with a special focus on mesoporous silica nanoparticle (MSNP) based materials.
Journal ArticleDOI

Continuous formation of supported cubic and hexagonal mesoporous films by sol–gel dip-coating

TL;DR: In this article, a solgel-based dip-coating method for the rapid synthesis of continuous mesoporous thin films on a solid substrate is presented, which can be used for membrane-based separations, selective catalysis and sensors.

Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug

TL;DR: Water-insoluble anticancer drugs were delivered into human cancer cells; surface conjugation with cancer-specific targeting agents increased the uptake into cancer cells relative to that in non-cancerous fibroblasts.